Friday’s stock movers reacted to earnings, product revenue growth, restructuring updates, Smart Cart deployments, and diagnostics demand.
Stock Earnings Results
May 16, 2026
Table of Contents
May 15, 2026
Stocks saw company-level reactions on Friday, with earnings results, product revenue growth, restructuring progress, Smart Cart deployments, and diagnostics revenue driving several notable moves.
Here are five stocks that reacted to major company events.
Move: -10.31%
Event: Wider-Than-Expected Loss Despite Revenue Growth
Shares of VolitionRx moved -10.31% after the company reported first-quarter results with strong year-over-year revenue growth, but a wider-than-expected loss.
VolitionRx is a diagnostics company developing blood-based tests using its Nu.Q technology platform, with applications across cancer detection, disease monitoring, and veterinary diagnostics.
The company reported a loss of $0.82 per share, wider than estimates for a loss of $0.70, representing a negative 17.1% earnings surprise. Revenue came in at $985,000, with revenue growth of 142.0%.
Why It Moved:
Investors focused on the earnings miss and ongoing cash needs. Revenue growth was supported by deferred revenue recognition tied to the Nu.Q Vet agreement with Heska, but operating expenses rose and profitability remains a concern.
Move: -12.50%
Event: Smart Cart Revenue Growth Despite Wider Loss
Shares of A2Z Cust2Mate moved -12.50% after the company reported strong revenue growth, supported by Smart Cart deployments and a large contracted backlog, but posted a wider-than-expected loss.
A2Z Cust2Mate develops smart shopping cart technology and retail automation solutions designed to improve in-store checkout, customer engagement, and retailer data collection.
The company reported a loss of $0.18 per share, wider than estimates for a loss of $0.06, representing a negative 200.0% earnings surprise. Revenue came in at $3.32 million, with revenue growth of 185.9%.
Why It Moved:
The market weighed strong commercial progress against profitability concerns. A2Z delivered more than 500 Smart Carts during the quarter and reported a backlog of more than 19,000 Smart Carts through 2027, but investors still want evidence that deployments can scale without losses widening.
Move: +1.24%
Event: Restructuring Progress Despite Wider-Than-Expected Loss
Shares of PAVmed moved +1.24% after the company reported first-quarter results that showed a wider-than-expected loss and minimal revenue, but highlighted restructuring progress and upcoming product-related milestones.
PAVmed is a medical technology holding company with subsidiaries and product platforms focused on diagnostics, digital health, and medical devices, including Lucid Diagnostics and Veris Health.
The company reported a loss of $4.47 per share, wider than estimates for a loss of $0.80, representing a negative 458.7% earnings surprise. Revenue came in at $22,000, below estimates of $100,000, but showed year-over-year growth of 175.0%.
Why It Moved:
Investors focused on the completed restructuring process, which simplified PAVmed’s capital structure by eliminating convertible preferred stock and debt instruments. The next major catalyst remains potential Medicare coverage for Lucid Diagnostics.
Move: -6.49%
Event: neffy Revenue Growth Despite Earnings Miss
Shares of ARS Pharmaceuticals moved -6.49% after the company reported revenue above expectations but posted a wider-than-expected loss.
ARS Pharmaceuticals is a biopharmaceutical company focused on severe allergic reaction treatments. Its lead product, neffy, is a needle-free epinephrine nasal spray used for emergency treatment of severe allergic reactions, including anaphylaxis.
The company reported a loss of $0.61 per share, wider than estimates for a loss of $0.53, representing a negative 15.1% earnings surprise. Revenue came in at $22.68 million, above estimates of $22.35 million, with revenue growth of 184.5%.
Why It Moved:
Investors weighed neffy adoption against rising commercial spending. ARS reported $17.5 million in U.S. neffy sales and more than 28,000 prescribers to date, but net loss widened as sales and marketing costs increased.
Move: -6.21%
Event: Revenue Beat Despite Wider-Than-Expected Loss
Shares of SurgePays moved -6.21% after the company reported first-quarter revenue above expectations, but a wider-than-expected loss.
SurgePays is a fintech and telecom services company that provides prepaid wireless, financial technology, and payment products through convenience stores and underserved retail channels.
The company reported a loss of $0.51 per share, wider than estimates for a loss of $0.19, representing a negative 168.4% earnings surprise. Revenue came in at $15.98 million, above estimates of $13.20 million, with revenue growth of 51.1%.
Why It Moved:
The revenue beat was not enough to offset profitability concerns. SurgePays grew its top line, but the earnings miss showed revenue growth has not yet translated into better bottom-line performance.
Today’s reactions show that investors are demanding more than revenue growth from small-cap healthcare, diagnostics, fintech, and retail technology companies.
Key themes included:
The strongest setups were companies where revenue growth came with a clearer commercial path or balance sheet improvement. The weakest setups were names where losses, spending, or financing needs overshadowed headline growth.
Friday’s earnings reactions show the market is separating growth stories from profitable growth stories.
A company can beat revenue estimates and still fall if losses widen. It can miss earnings and still rise if restructuring improves the balance sheet. The key is whether the event changes the forward outlook.
Platforms like LevelFields track earnings beats, activist investor stake, layoffs, earnings, strategic events, and dividends, helping investors identify which company events are actually driving short-term stock reactions.
Join LevelFields now to be the first to know about events that affect stock prices and uncover unique investment opportunities. Choose from events, view price reactions, and set event alerts with our AI-powered platform. Don't miss out on daily opportunities from 6,300 companies monitored 24/7. Act on facts, not opinions, and let LevelFields help you become a better investor.
AI scans for events proven to impact stock prices, so you don't have to.
LEARN MORE